Kerry Bradley

Kerry Bradley is the VP of Scientific Affairs at Nevro. Kerry has over 15 years of experience in the biomedical field, with a focus on neuromodulation therapies. Kerry started their career as a Principal Biomedical Systems Engineer at Boston Scientific, where they designed and executed clinical studies, trained sites, and worked with physicians and patients in-clinic. Kerry then transitioned to a Manager role, leading a team of 5 scientists to investigate a wide range of neuromodulation therapies and targets.

Kerry is a well-respected authority in their field, and has presented their findings at multiple neuromodulation conferences. Kerry is also the co-author of 6 peer-reviewed journal articles and a biomedical engineering book chapter. In their current role at Nevro, Kerry is responsible for overseeing the scientific affairs of the company and ensuring that all products meet the highest standards of safety and efficacy.

Kerry Bradley attended California Polytechnic State University-San Luis Obispo for both their BS and MS in Electronic Engineering. Kerry also attended PGHS, but it is not clear what they studied there.

Kerry Bradley reports to D. Keith Grossman, Chairman, CEO & President. Some of their coworkers include Jon Shear - VP, Corporate Development, David Caraway - Chief Medical Officer, and Jon Parker - VP, Product Development.